Titanium Dioxide Nanoparticles Enhance Radiation Response in Triple-Negative Breast Cancer Cells Under Megavoltage X-Ray Irradiation

Information from the abstract

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype associated with radioresistance and limited treatment options. Titanium dioxide nanoparticles (TiO2-NPs) have attracted attention as potential radiosensitizers because they can enhance radiation-induced oxidative stress. This study evaluated the radiosensitizing effects of BSA-adsorbed TiO2-NPs in MDA-MB-231 TNBC cells exposed to clinically relevant 6 MV X-ray irradiation. FITC-based cellular association, as an indicator of potential nanoparticle uptake, metabolic activity, clonogenic survival, sensitizer enhancement ratio (SER), reactive oxygen species (ROS), γ-H2AX positivity, and apoptosis were assessed. Flow cytometric analysis showed that approximately 55% of cells were FITC-positive after 24 h of exposure, while approximately 90% metabolic activity was maintained at the selected concentration (25 µg/mL). Combined treatment significantly reduced the surviving fraction from 0.81 to 0.37 after 2 Gy irradiation and yielded SER values of 1.21 and 1.59 at SER10 and SER37, respectively. In addition, combined treatment produced the greatest increases in intracellular ROS generation, γ-H2AX positivity, and apoptosis compared with either treatment alone. These findings indicate that BSA-adsorbed TiO2-NPs increase the radiosensitivity of TNBC cells under clinically relevant megavoltage irradiation and support their further evaluation as potential radiosensitizers for breast cancer radiotherapy.

Why this record is monitored

This record has an Impact Signal of 78/100 based on recency, source, collaboration, and bibliographic signals. It prioritizes monitoring and is not a judgment of research quality.

Related topics: Radiation Therapy and Dosimetry · Effects of Radiation Exposure · Nanoplatforms for cancer theranostics